BMK.L
Benchmark Holdings plc [BMK.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
BMK.L Stock Summary
Top 10 Correlated Stocks
BMK.L
In the News
BMK.L Financial details
Company Rating
Buy
Market Cap
302.37M
Income
-25.09M
Revenue
177.89M
Book val./share
0.41
Cash/share
0.05
Dividend
-
Dividend %
-
Employees
847
Optionable
No
Shortable
Yes
Earnings
23 May 2023
P/E
-1178.87
Forward P/E
-
PEG
-111.45
P/S
1.7
P/B
100.7
P/C
818
P/FCF
34.74
Quick Ratio
0.63
Current Ratio
2.21
Debt / Equity
0.6
LT Debt / Equity
0.28
-
-
EPS (TTM)
-0.04
EPS next Y
0
EPS next Q
-
EPS this Y
152.02%
EPS next Y
-100%
EPS next 5Y
-100%
EPS last 5Y
35.96%
Revenue last 5Y
0.88%
Revenue Q/Q
-18.59%
EPS Q/Q
280%
-
-
-
-
SMA20
1.45%
SMA50
12.06%
SMA100
8.37%
Inst Own
-
Inst Trans
-
ROA
-5%
ROE
-8%
ROC
0.03%
Gross Margin
52%
Oper. Margin
7%
Profit Margin
-14%
Payout
-
Shs Outstand
739.3M
Shs Float
214.25M
-
-
-
-
Target Price
-
52W Range
33.0-54.0
52W High
-24.26%
52W Low
+23.94%
RSI
53.7
Rel Volume
0.01
Avg Volume
540.72K
Volume
6.66K
Perf Week
2.25%
Perf Month
12.67%
Perf Quarter
2.25%
Perf Half Y
7.63%
-
-
-
-
Beta
0.75822
-
-
Volatility
0.63%, 2%
Prev Close
2.25%
Price
40.9
Change
-0.24%
BMK.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-09-30
| Metric | History | 2018-09-30 | 2019-09-30 | 2020-09-30 | 2021-09-30 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.28 | 0.23 | 0.17 | 0.19 | 0.23 | |
| Net income per share | -0.01 | -0.13 | -0.04 | -0.02 | -0.04 | |
| Operating cash flow per share | -0.01 | -0.02 | -0.01 | 0.01 | 0.02 | |
| Free cash flow per share | -0.07 | -0.04 | -0.02 | -0.03 | 0 | |
| Cash per share | 0.05 | 0.03 | 0.11 | 0.06 | 0.05 | |
| Book value per share | 0.71 | 0.55 | 0.46 | 0.41 | 0.45 | |
| Tangible book value per share | 0.11 | 0.06 | 0.08 | 0.08 | 0.11 | |
| Share holders equity per share | 0.71 | 0.55 | 0.46 | 0.41 | 0.45 | |
| Interest debt per share | 0.15 | 0.2 | 0.19 | 0.19 | 0.17 | |
| Market cap | 324.31M | 264.53M | 268.95M | 408.37M | 273.71M | |
| Enterprise value | 379.98M | 351.67M | 306.5M | 489.3M | 347.44M | |
| P/E ratio | -64.74 | -3.61 | -11.81 | -35.28 | -8.99 | |
| Price to sales ratio | 2.14 | 2.08 | 2.55 | 3.27 | 1.73 | |
| POCF ratio | -86.69 | -28.72 | -66.31 | 70.53 | 25.32 | |
| PFCF ratio | -8.91 | -10.57 | -17.39 | -24.12 | -143.23 | |
| P/B Ratio | 0.86 | 0.87 | 0.93 | 1.5 | 0.87 | |
| PTB ratio | 0.86 | 0.87 | 0.93 | 1.5 | 0.87 | |
| EV to sales | 2.51 | 2.76 | 2.9 | 3.91 | 2.2 | |
| Enterprise value over EBITDA | 29.24 | 19.15 | 14.69 | 20.7 | 10.13 | |
| EV to operating cash flow | -101.57 | -38.18 | -75.57 | 84.51 | 32.14 | |
| EV to free cash flow | -10.44 | -14.05 | -19.81 | -28.9 | -181.81 | |
| Earnings yield | -0.02 | -0.28 | -0.08 | -0.03 | -0.11 | |
| Free cash flow yield | -0.11 | -0.09 | -0.06 | -0.04 | -0.01 | |
| Debt to equity | 0.45 | 0.63 | 0.67 | 0.74 | 0.65 | |
| Debt to assets | 0.31 | 0.38 | 0.4 | 0.42 | 0.39 | |
| Net debt to EBITDA | 4.28 | 4.75 | 1.8 | 3.42 | 2.15 | |
| Current ratio | 1.98 | 2.35 | 2.63 | 1.95 | 2.03 | |
| Interest coverage | -3.07 | -10.66 | -0.6 | -0.13 | -0.42 | |
| Income quality | 0.75 | 0.11 | 0.13 | -0.5 | -0.35 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.08 | 0.1 | 0.07 | 0.06 | 0.04 | |
| Intangibles to total assets | 0.59 | 0.55 | 0.51 | 0.48 | 0.47 | |
| Capex to operating cash flow | 8.73 | 1.72 | 2.81 | -3.92 | -1.18 | |
| Capex to revenue | -0.22 | -0.12 | -0.11 | -0.18 | -0.08 | |
| Capex to depreciation | -1.31 | -0.19 | -0.4 | -0.92 | -0.33 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | |
| Graham number | 0.39 | 1.27 | 0.62 | 0.4 | 0.66 | |
| ROIC | -0.01 | -0.15 | -0.03 | 0 | -0.02 | |
| Return on tangible assets | -0.02 | -0.32 | -0.09 | -0.05 | -0.11 | |
| Graham Net | -0.25 | -0.28 | -0.17 | -0.21 | -0.2 | |
| Working capital | 48.53M | 70.58M | 90.38M | 60.51M | 75.11M | |
| Tangible asset value | 56.46M | 34.72M | 48.44M | 50.56M | 78.02M | |
| Net current asset value | -73.2M | -70.13M | -47.85M | -78.37M | -54.92M | |
| Invested capital | 0.21 | 0.34 | 0.38 | 0.44 | 0.35 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 45.09M | 40.46M | 40.46M | 46.18M | 45.5M | |
| Average inventory | 31.61M | 35.5M | 36.7M | 36.42M | 46.83M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 215.29 | 209.64 | 329.58 | 286.39 | 215.28 | |
| Days of inventory on hand | 152.58 | 229.85 | 250.83 | 233.62 | 270.02 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 1.7 | 1.74 | 1.11 | 1.27 | 1.7 | |
| Inventory turnover | 2.39 | 1.59 | 1.46 | 1.56 | 1.35 | |
| ROE | -0.01 | -0.24 | -0.08 | -0.04 | -0.1 | |
| Capex per share | -0.06 | -0.03 | -0.02 | -0.03 | -0.02 |
Quarterly Fundamentals Overview
Last date of statement is 2023-03-31 for Q2
| Metric | History | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.06 | 0.05 | 0.06 | 0.08 | 0.06 | |
| Net income per share | -0.01 | -0.02 | -0.01 | 0 | 0 | |
| Operating cash flow per share | 0 | -0.01 | 0.02 | 0.01 | 0 | |
| Free cash flow per share | 0 | -0.01 | 0.01 | 0.01 | 0 | |
| Cash per share | 0.07 | 0.05 | 0.05 | 0.06 | 0.05 | |
| Book value per share | 0.42 | 0.42 | 0.45 | 0.43 | 0.41 | |
| Tangible book value per share | 0.43 | 0.43 | 0.46 | 0.44 | 0.41 | |
| Share holders equity per share | 0.42 | 0.42 | 0.45 | 0.43 | 0.41 | |
| Interest debt per share | 0.19 | 0.19 | 0.17 | 0.16 | 0.15 | |
| Market cap | 354.78M | 334.38M | 275.95M | 262.73M | 253.11M | |
| Enterprise value | 436.22M | 423.52M | 349.69M | 324.14M | 319.46M | |
| P/E ratio | -24.29 | -6.52 | -7.78 | -96.73 | -23.26 | |
| Price to sales ratio | 9.04 | 9.22 | 6.45 | 4.82 | 5.7 | |
| POCF ratio | 432.13 | -80.46 | 21.21 | 32.56 | 178 | |
| PFCF ratio | -111.15 | -51.64 | 29.94 | 42.69 | -1.31K | |
| P/B Ratio | 1.21 | 1.13 | 0.88 | 0.86 | 0.86 | |
| PTB ratio | 1.21 | 1.13 | 0.88 | 0.86 | 0.86 | |
| EV to sales | 11.12 | 11.68 | 8.18 | 5.95 | 7.2 | |
| Enterprise value over EBITDA | 42.13 | 63.26 | 22.92 | 17.54 | 26.88 | |
| EV to operating cash flow | 531.32 | -101.91 | 26.88 | 40.18 | 224.65 | |
| EV to free cash flow | -136.66 | -65.41 | 37.94 | 52.66 | -1.66K | |
| Earnings yield | -0.01 | -0.04 | -0.03 | 0 | -0.01 | |
| Free cash flow yield | -0.01 | -0.02 | 0.03 | 0.02 | 0 | |
| Debt to equity | 0.67 | 0.7 | 0.65 | 0.59 | 0.6 | |
| Debt to assets | 0.4 | 0.4 | 0.39 | 0.36 | 0.37 | |
| Net debt to EBITDA | 7.86 | 13.31 | 4.83 | 3.32 | 5.58 | |
| Current ratio | 2.54 | 2.21 | 2.03 | 2.2 | 2.21 | |
| Interest coverage | 0.12 | -0.45 | 0.45 | 1.15 | 0.91 | |
| Income quality | -0.22 | 0.32 | -1.47 | -11.88 | -0.52 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.04 | 0.04 | 0.05 | 0.03 | 0.03 | |
| Intangibles to total assets | 0.45 | 0.46 | 0.47 | 0.45 | 0.45 | |
| Capex to operating cash flow | -4.89 | 0.56 | -0.29 | -0.24 | -1.14 | |
| Capex to revenue | -0.1 | -0.06 | -0.09 | -0.04 | -0.04 | |
| Capex to depreciation | -0.4 | -0.23 | -0.38 | -0.19 | -0.18 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham number | 0.22 | 0.41 | 0.36 | 0.1 | 0.19 | |
| ROIC | 0 | -0.01 | 0.02 | -0.15 | 0.01 | |
| Return on tangible assets | -0.01 | -0.05 | -0.03 | 0 | -0.01 | |
| Graham Net | -0.18 | -0.2 | -0.2 | -0.16 | -0.15 | |
| Working capital | 84.89M | 76.73M | 75.11M | 75.9M | 74.93M | |
| Tangible asset value | 75.1M | 69.03M | 78.02M | 91.26M | 84.04M | |
| Net current asset value | -57.76M | -65.54M | -54.92M | -41.53M | -38.49M | |
| Invested capital | 0.44 | 0.43 | 0.35 | 0.34 | 0.36 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 36.14M | 37.26M | 42.78M | 39.79M | 32.49M | |
| Average inventory | 42.46M | 48.65M | 53.23M | 50.48M | 47.53M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 155.94 | 220.96 | 214.18 | 104.83 | 136.84 | |
| Days of inventory on hand | 217.55 | 272.5 | 268.64 | 134.92 | 228.71 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0.58 | 0.41 | 0.42 | 0.86 | 0.66 | |
| Inventory turnover | 0.41 | 0.33 | 0.34 | 0.67 | 0.39 | |
| ROE | -0.01 | -0.04 | -0.03 | 0 | -0.01 | |
| Capex per share | -0.01 | 0 | -0.01 | 0 | 0 |
BMK.L Frequently Asked Questions
What is Benchmark Holdings plc stock symbol ?
Benchmark Holdings plc is a GB stock and trading under the symbol BMK.L
What is Benchmark Holdings plc stock quote today ?
Benchmark Holdings plc stock price is $40.9 today.
Is Benchmark Holdings plc stock public?
Yes, Benchmark Holdings plc is a publicly traded company.
Company Profile
- Volume Average 540.72K
- Market Capitalization 302.37M
- Employee 847
- CEO Mr. Trond Williksen
- Headquarters Sheffield,GB
- IPO Date 2013-12-18
-
Website
https://www.benchmarkplc.com 
Benchmark Holdings plc, together with its subsidiaries, provides technical services, products, and specialist knowledge that supports the development of food and farming industries in the United Kingdom, Norway, the Faroe Islands, Ecuador, India, Greece, Singapore, Chile, Turkey, rest of the Europe, and internationally. The company operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers salmon breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products to the aquaculture market. Benchmark Holdings plc was founded in 2000 and is based in Sheffield, the United Kingdom.
